Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 4, keine Gesamtzahl für „Reported“
Suchtreffer
Begriffe & Kennungen
Adjupanrix (previously Pandemic influenza vaccine (H5N1) (split virion, inactivated, adjuvanted) GlaxoSmithKline Biologicals) · 4.8 · 5 List of adverse reactions Adverse reactions reported are listed according to the following frequency:
Eintrag öffnenAdjupanrix (previously Pandemic influenza vaccine (H5N1) (split virion, inactivated, adjuvanted) GlaxoSmithKline Biologicals) · 4.8 · Frequencies are reported as: Very common (1/10) Common ( 1/100 to < 1/10) Uncommon ( 1/1 000 to < 1/100) Ra
Eintrag öffnenAdjupanrix (previously Pandemic influenza vaccine (H5N1) (split virion, inactivated, adjuvanted) GlaxoSmithKline Biologicals) · 4.8 · The following adverse reactions per dose have been reported:
Eintrag öffnenAdrovance · 4.8 · Summary of the safety profile The most commonly reported adverse reactions are upper gastrointestinal adverse
Eintrag öffnenAdrovance · 4.8 · Tabulated list of adverse reactions The following adverse reactions have been reported during clinical studies
Eintrag öffnenAdtralza · 4.8 · Eczema herpeticum Eczema herpeticum was reported in 0.3% of the subjects treated with tralokinumab and in 1.5%
Eintrag öffnenAdtralza · 4.8 · Eosinophilia Adverse reactions of eosinophilia were reported in 1.3% of patients treated with tralokinumab and
Eintrag öffnenAdtralza · 4.8 · Keratitis was reported in 0.5% of subjects treated with tralokinumab during the initial treatment period. Of t
Eintrag öffnenAdtralza · 4.8 · The most common adverse reactions are upper respiratory tract infections (23.4%; mainly reported as common col
Eintrag öffnenAdvagraf · 4.8 · The most commonly reported adverse reactions (occurring in > 10% of patients) are tremor, renal impairment, hy
Eintrag öffnenAdynovi · 4.8 · 24 Table 2: Adverse reactions reported for ADYNOVI
Eintrag öffnenAdynovi · 4.8 · Table 2: Adverse reactions reported for ADYNOVI
Eintrag öffnenAerinaze · 4.8 · 7 Other adverse reactions reported for desloratadine during the post-marketing period are listed hereunder.
Eintrag öffnenAerinaze · 4.8 · Cases of severe skin reactions such as acute generalised exanthematous pustulosis (AGEP) have been reported wi
Eintrag öffnenAerinaze · 4.8 · Other adverse reactions reported for pseudoephedrine-containing products during the post-marketing period are
Eintrag öffnenAerius · 4.8 · Paediatric population Other undesirable effects reported during the post-marketing period in paediatric patien
Eintrag öffnenAerius · 4.8 · Paediatric population Other undesirable effects reported during the post-marketing period in paediatric patien
Eintrag öffnenAerius · 4.8 · Tabulated list of adverse reactions The frequency of the clinical trial adverse reactions reported in excess o
Eintrag öffnenAerius · 4.8 · Tabulated list of adverse reactions The frequency of the clinical trial adverse reactions reported in excess o
Eintrag öffnenAfinitor · 4.5 · Potentiation of radiation treatment toxicity has been reported in patients receiving everolimus (see sections
Eintrag öffnen